Life Science REIT (LON:LABS) Trading Down 4.9% – Here’s What Happened

Life Science REIT plc (LON:LABS)’s share price traded down 4.9% on Monday . The company traded as low as GBX 39 ($0.49) and last traded at GBX 39 ($0.49). 583,238 shares changed hands during trading, a decline of 43% from the average session volume of 1,031,143 shares. The stock had previously closed at GBX 41 ($0.52).

Analysts Set New Price Targets

Several research analysts have recently weighed in on LABS shares. Berenberg Bank reissued a “buy” rating and issued a GBX 57 ($0.72) price objective on shares of Life Science REIT in a research report on Thursday, October 3rd. Shore Capital reiterated a “buy” rating on shares of Life Science REIT in a report on Thursday, September 26th. Finally, Jefferies Financial Group reduced their price objective on shares of Life Science REIT from GBX 45 ($0.57) to GBX 36 ($0.46) and set a “hold” rating for the company in a research report on Friday, August 30th.

Life Science REIT Stock Performance

The company has a market capitalization of £138.95 million, a price-to-earnings ratio of -658.00 and a beta of 0.08. The company has a 50 day moving average price of GBX 38.62 and a 200 day moving average price of GBX 36.13.

Life Science REIT Dividend Announcement

The company also recently disclosed a dividend, which was paid on Thursday, October 31st. Shareholders of record on Thursday, October 3rd were paid a GBX 1 ($0.01) dividend. The ex-dividend date of this dividend was Thursday, October 3rd. This represents a yield of 3.11%. Life Science REIT’s dividend payout ratio (DPR) is presently -3,333.33%.

About Life Science REIT

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.